Ireland
--:--IST
Starting soon Not applicable

Polynucleotide-Hyaluronic Acid Gel With Xenograft for Alveolar Ridge Preservation

NCT07771257 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-08-18

Condition(s) studied

Alveolar Ridge Preservation

Investigational drug(s) / intervention(s)

Polynucleotide-Hyaluronic Acid Gel With XenograftXenograft With Collagen Membrane

Polynucleotide-Hyaluronic Acid Gel With Xenograft: Xenograft mixed with polynucleotide-hyaluronic acid gel and covered with a collagen membrane for alveolar ridge preservation after tooth extraction.

Xenograft With Collagen Membrane: Xenograft placed in the extraction socket and covered with a collagen membrane for alveolar ridge preservation after tooth extraction.

Study summary

This randomized controlled clinical trial will evaluate the efficacy of polynucleotide-hyaluronic acid gel combined with xenograft and collagen membrane for alveolar ridge preservation following tooth extraction. Twenty participants will be randomly allocated into two parallel groups. The test group will receive xenograft mixed with polynucleotide-hyaluronic acid gel and covered with a collagen membrane, while the control group will receive xenograft with a collagen membrane alone. Clinical and CBCT assessments will be performed at baseline and during follow-up. After 6 months, ridge dimensional changes will be evaluated and core biopsies will be obtained at the time of implant placement for histological assessment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18-60 years. * Patients free from systemic diseases affecting wound healing or bone regeneration or contraindicating oral surgery. * Non-smokers with good oral hygiene. * Patients requiring tooth extraction in non-infected sockets due to endodontic failure, non-restorable caries, or trauma, and who will receive implant treatment. * Class I extraction sockets with intact alveolar bone walls. * Presence of teeth adjacent to the extraction site. Exclusion Criteria: * Use of drugs affecting wound healing. * Heavy smokers (\>10 cigarettes/day) or history of substance abuse. * Pregnant or breastfeeding women. * Previous grafting or surgical intervention in the study area. * Uncontrolled and/or untreated periodontal disease (active periodontitis). * Mentally or physically handicapped patients.

Primary outcome measure(s)

  • Change in Buccal Bone Plate Height — Baseline and 6 months
    The height of the buccal bone plate will be measured using digital superimposition of Cone Beam Computed Tomography (CBCT) scans obtained at baseline and 6 months. Measurements will be recorded in millimeters

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, Cairo University Cairo Cairo Governorate
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07771257 on ClinicalTrials.gov ↗ ← All trials in Egypt